Drawing for QIASYMPHONY

USPTO serial 79037734

QIASYMPHONY

Reviewed by CopyMark Law Group

Reg. 3445463Status 706Registered
Filing date
Status date
Registration date
Jun 10, 2008
Examiner
SETTLES LEWIS, SHAILA E
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with QIASYMPHONY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Victoria Friedman

Victoria Friedman Dennemeyer & Associates, LLC2 North Riverside Plaza, Suite 1500CHICAGO, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biotechnological products for industrial and scientific purposes, in particular nucleic acids, enzymes, polymerases, [ reagents for staining and marking, molecular probes, ] buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate and gel form and magnetic particles in fluid form, none of the foregoing for medical or veterinary purposes; Materials for columns and reagents and solvents for sample preparation, all of the foregoing for the purpose of purification, lysis, modification and manipulation of cells, as well as for the performance of [ marking, ] separation, isolation, purification, [ amplification and analytical ] methods for biopolymers, in particular nucleic acids, [ enzymes, proteins, ] macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; Kits comprising chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and manipulation of cells as well as for the performance of [ marking, ] separation, isolation, purification, [ amplification and analytical ] methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, in particular nucleic acids made from biological and biochemical sample material, none of the foregoing for medical or veterinary purposesACTIVE—
005Products for medical and veterinary medical purposes, in particular diagnostic preparations, in particular nucleic acids, enzymes, polymerases, [ reagents for staining and marking, molecular probes, ] buffer chemicals and aqueous and non-aqueous solutions of primary, secondary and tertiary alcohols and salts, distilled and purified water, magnetic particles in fluid form, and materials for columns for the purpose of purification, lysis, modification and manipulation of cells, as well as for the performance of [ marking, ] separation, isolation, purification, [ amplification and analytical ] methods for biopolymers, in particular nucleic acids, [ enzymes, proteins, ] macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, all of the foregoing for medical and veterinary purposes; Products for medical and veterinary medical purposes, namely, chemical, biochemical and biotechnological products as well as kits comprising products for medical and veterinary medical purposes, in particular chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and manipulation of cells, as well as for the performance of [ marking, ] separation, isolation, purification, [ amplification and analytical ]methods for biopolymers, in particular nucleic acids for medical and veterinary medical purposes, [ enzymes, natural and artificial proteins, ] macro molecules, and biologically active substances for detecting pathogens, genetic information and conditions of the human bodyACTIVE—
009Scientific apparatus, instruments and equipment for research and examination purposes, namely, laboratory equipment, namely, [ chromatography columns; ] automated laboratory equipment, namely, robots and spare parts and add-ons therefor, namely, preprogrammed smart cards for DNA purification protocols; laboratory equipment, namely, microplates; laboratory equipment, namely, pipettes, pipette tips and pipette tip holders; laboratory equipment, namely, sample containers, reagent holders, flasks, reagent tube holders, holders for micro containers, [ magnetic syringes, ][ biochips for the purpose of screen large numbers of biological analytes, ] thermocyclers for the purpose of performing polymerase chain reactions, [ homogenizers for the purpose of breaking up cell membranes and mixing the resulting liquids, and vacuum valves for the purpose of permitting the operation of laboratory processes under subatmospheric pressure, ] all of the aforementioned being included in this class and being for scientific research and examination purposesACTIVE—
042[ Scientific research for others in the fields of chemistry, genetics, biology and biochemistry; Scientific diagnostic services for others in the fields of DNA, RNA and protein detection and analysis; Research services in the field of forensic science, namely, analysis, detection and isolation of biological substances in forensic samples ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 30, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
Feb 10, 2019INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Feb 6, 2019INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 6, 2018NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jun 6, 201871AGREGISTERED-SEC.71 ACCEPTED—
May 31, 2018ES71TEAS SECTION 71 RECEIVED—
Jun 10, 2017REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Sep 15, 2016RNWLINTERNATIONAL REGISTRATION RENEWED—
Aug 7, 2015INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jul 17, 2015INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 17, 2015INPCINVALIDATION PROCESSED—
Mar 23, 2015INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 23, 2014NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jul 23, 2014C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jun 24, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 4, 2014ES75TEAS SECTION 71 & 15 RECEIVED—
Dec 30, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 14, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 14, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 29, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 29, 2008FIMPFINAL DISPOSITION PROCESSED—
Sep 10, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 10, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 25, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 5, 2008NPUBNOTICE OF PUBLICATION—
Feb 20, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 20, 2008ALIEASSIGNED TO LIE—
Jan 18, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 14, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Jan 14, 2008GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 14, 2008GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 14, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 21, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 21, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 21, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2007FAXXFAX RECEIVED—
Jul 20, 2007RFNTREFUSAL PROCESSED BY IB—
Jul 18, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 28, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 28, 2007RFRRREFUSAL PROCESSED BY MPU—
Jun 28, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 27, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 2007DOCKASSIGNED TO EXAMINER—
Jun 8, 2007NWAPNEW APPLICATION ENTERED—
Jun 7, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance